Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Karlsson

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
EJIFCC|December 12, 2018
Leptin - a slimmer's dream that crashed?Cecilia Karlsson
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2018
Development of Human Target Validation Classification that Predicts Future Clinical EfficacyCecilia Karlsson, Peter J Greasley, David Gustafsson, et al.
Communications Biology|October 1, 2022
Visual odometry of Rhinecanthus aculeatus depends on the visual density of the environmentCecilia Karlsson, Jay Willis, Matishalin Patel, et al.
Ebiomedicine|May 18, 2026
Adiposity-based obesity classification and cardiometabolic and kidney outcomes: a longitudinal UK Biobank analysisSophie Gunnarsson, Cecilia Karlsson, Rashmi B Prasad, et al.
Trends in Endocrinology and Metabolism: TEM|February 11, 2025
Glucagon-like peptide-1 receptor agonism and end-organ protectionSamuel Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Proceedings. Biological Sciences|December 8, 2022
Distance estimation in the goldfish (<i>Carassius auratus</i>)Adelaide Sibeaux, Cecilia Karlsson, Cait Newport, et al.
Endocrinology|December 31, 2014
Baseline anandamide levels and body weight impact the weight loss effect of CB1 receptor antagonism in male ratsCecilia Karlsson, Stephan Hjorth, Martin Karpefors, et al.
Biochemical and Biophysical Research Communications|April 11, 2009
Fetal hepatic expression of 5-lipoxygenase activating protein is confined to colonizing hematopoietic cellsTobias Strid, Cecilia Karlsson, Mats Söderström, et al.
Communications Biology|May 16, 2024
Taking a shortcut: what mechanisms do fish use?Adelaide Sibeaux, Cait Newport, Jonathan P Green, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin or Saxagliptin in Pediatric Type 2 DiabetesNaim Shehadeh, Timothy Barrett, Pietro Galassetti, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
EJIFCC|December 12, 2018
Leptin - a slimmer's dream that crashed?Cecilia Karlsson
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2018
Development of Human Target Validation Classification that Predicts Future Clinical EfficacyCecilia Karlsson, Peter J Greasley, David Gustafsson, et al.
Communications Biology|October 1, 2022
Visual odometry of Rhinecanthus aculeatus depends on the visual density of the environmentCecilia Karlsson, Jay Willis, Matishalin Patel, et al.
Ebiomedicine|May 18, 2026
Adiposity-based obesity classification and cardiometabolic and kidney outcomes: a longitudinal UK Biobank analysisSophie Gunnarsson, Cecilia Karlsson, Rashmi B Prasad, et al.
Trends in Endocrinology and Metabolism: TEM|February 11, 2025
Glucagon-like peptide-1 receptor agonism and end-organ protectionSamuel Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Proceedings. Biological Sciences|December 8, 2022
Distance estimation in the goldfish (<i>Carassius auratus</i>)Adelaide Sibeaux, Cecilia Karlsson, Cait Newport, et al.
Endocrinology|December 31, 2014
Baseline anandamide levels and body weight impact the weight loss effect of CB1 receptor antagonism in male ratsCecilia Karlsson, Stephan Hjorth, Martin Karpefors, et al.
Biochemical and Biophysical Research Communications|April 11, 2009
Fetal hepatic expression of 5-lipoxygenase activating protein is confined to colonizing hematopoietic cellsTobias Strid, Cecilia Karlsson, Mats Söderström, et al.
Communications Biology|May 16, 2024
Taking a shortcut: what mechanisms do fish use?Adelaide Sibeaux, Cait Newport, Jonathan P Green, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin or Saxagliptin in Pediatric Type 2 DiabetesNaim Shehadeh, Timothy Barrett, Pietro Galassetti, et al.
Pageof 6